Sign inJoin waitlistJoin the waitlist

AL

Abraham Leung

Hematology & Oncology

Credentials: ·

Research

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · 569 citations
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Cancer Discovery · 2018 · 269 citations
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study
Molecular Cancer Therapeutics · 2023 · 28 citations

Antoni Ribas
1 paper
Anusha Kalbasi
1 paper
Asim Amin
1 paper
Deborah Wong
1 paper
ES
Emmett Schmidt
1 paper
Funda Meric-Bernstam
1 paper
Gregory Daniels
1 paper
IK
Ian Krop
1 paper
Joseph Drabick
1 paper
MS
Melanie Smitt
1 paper
MB
Minal Barve
1 paper
Patricia LoRusso
1 paper